The independent platform for news, articles and advice for professionals in laboratory medicine

CORONAVIRUS NEWS

Whole pathogen molecular controls for SARS-CoV-2 receive CE marking

CE marking has been granted to whole-pathogen quality controls for SARS-CoV-2, from global diagnostics company Randox Laboratories. The molecular controls are currently being used alongside the firm’s coronavirus tests, performed on its proprietary Biochip, as part of a nationwide UK testing programme.

Coronavirus sample collection kit manufacturing and supply contracts secured

EKF Diagnostics has secured new contracts for the manufacture and supply of a novel, patented sample collection device which allows SARS-CoV-2 coronavirus samples to be rapidly inactivated in the collection tube, avoiding contamination and preserving RNA without need for refrigeration. To support the increase in testing globally, a safe and easy sample collection and transport mechanism is essential, and this is provided by the PrimeStore MTM sample collection device.

Expansion of SARS-CoV-2 testing to include a total antibody test

Siemens Healthineers is expanding its infectious disease testing capabilities to aid in the SARS-CoV-2 pandemic. Recognising the critical need for accurate diagnostic testing, the company has developed a laboratory-based total antibody test to detect the presence of SARS-CoV-2 antibodies in blood.

Microchip RT-PCR coronavirus detection system announced

The current pandemic has created a demand for test kits that can be run with less amount of reagents while generating faster test results. Lumex Instruments’ microchip real-time PCR analyser, AriaDNA, by detecting SARS-CoV-2, has proven its ability to meet this demand. The Microchip RT-PCR coronavirus detection system based on AriaDNA can test up to seven patient samples in one run, which takes less than an hour, with low reagent consumption.

High-performance SARS-CoV-2 antibody test for humans launched by IDvet

IDvet, a company specialising in the development and production of diagnostic tests for the detection of infectious diseases in farm animals, has announced the commercial launch of a SARS-CoV-2 antibody test for humans.

Living with the pandemic in low- and middle-income countries: a webinar

In the first of a new webinar series, University of Birmingham experts will discuss how research can help people living in low- and middle-income countries (LMICs) to stay safe during the current coronavirus pandemic. Click on this story to registration for this free webinar, to be held on Thursday 21 May.

Coronavirus: new fast and accurate antibody test system developed

A serological screening machine with a claimed capacity of up to 3000 tests a day that produces results in 35 minutes with 99.8% accuracy has been developed by Quotient in Scotland and Switzerland. The blood-screening firm is now keen to hold talks with UK ministers amid interest from Europe for the machines.

Coronavirus antibody test authorisation by Public Health England: comment from BIVDA

The British In Vitro Diagnostics Association (BIVDA) has commented on recent media headlines as testing continues to underpin the fight against the SARS-CoV-2 coronavirus.

Contract secured to manufacture coronavirus test kits

New antibody test kits for ongoing SARS-CoV-2 coronavirus testing and immunity research are now being manufactured in Essex. Europlaz Technologies, based in Southminster, has signed an exclusive contract to manufacture antibody test kits.

Coagulopathy in COVID-19 patients: latest data, recommendations and perspectives

The International Society on Thrombosis and Haemostasis (ISTH) and European Hematology Association (EHA) are collaborating to present a new webinar on coagulopathy in COVID-19 patients, to be held on 14 May (3.00 pm BST). Click on this story for the link to register for this free webinar.

Development of a point-of-care, saliva-based antigen test strip for SARS-CoV-2

Avacta Group, the developer of Affimer biotherapeutics and reagents, has shipped Affimer reagents for SARS-COV-2 antigen testing to its diagnostic test development partners. The Group recently reported that it had generated multiple, highly specific Affimer reagents that bind the SARS-COV-2 viral antigen and do not cross-react with SARS, MERS and other closely related coronaviruses.

Coagulation alterations and management of patients with COVID-19 infection

Stago UK recently hosted a webinar on ‘Coagulation alterations and management of patients with COVID-19 infection’. The presenter, Professor Armando D’Angelo, has been involved in the management of COVID-19 patients in Italy’s Lombardy region, one of the worst affected areas in the world. Click on this story for links to free Stago webinars.

Digital pathology software: expanding availability

Recently, Proscia made available its Concentriq Dx digital pathology software for use in clinical practice in the USA, following Food and Drug Administration (FDA) guidance to provide a policy to help expand the availability of devices for remote reviewing and reporting of scanned digital images of pathology slides.

Free EQA scheme for UFH anti-Xa measurement now available

The role of unfractionated heparin (UFH) has come to the fore in the battle to save COVID -19 patients. With laboratories facing increased demand to measure anti-Xa activity, Stago UK is offering free enrolment in its Qualiris EQA scheme for UFH, which includes an anti-Xa assay peer group.

Acute-phase coronavirus rapid antigen test

Now available from BioConnections, COVID-19 Ag Respi-Strip detects the presence of SARS-CoV-2 antigens in a nasopharyngeal swab in 15 minutes in more than seven out of 10 patients with the high viral load (Cycle threshold [Ct] <25; an inverse measure of the target [virus] concentration) found in the acute phase of COVID-19.

Urgent research priorities for COVID-19: expert summary

The Academy of Medical Sciences and the British Society for Immunology established an expert advisory group in early April 2020. Together, the experts reviewed the limited research that is currently available and identified key research priorities.

Coronavirus antibody test: emergency authorisation

Roche has announced that the US Food and Drug Administration (FDA) has issued an Emergency Use Authorisation (EUA) for its new Elecsys Anti-SARS-CoV-2 antibody test, which is designed to help determine if a patient has been exposed to the SARS-CoV-2 virus and if the patient has developed antibodies against SARS-CoV-2.

Supporting staff, customers and local communities

CellPath is proud to supply the tools to make cancer diagnosis possible. Faced with the coronavirus outbreak, the company remains committed to supporting its customers’ crucial work. During this time, it is also necessary to protect valuable staff and the local community by ensuring the mid-Wales premises is safe for all.

First connected management system to accelerate SARS-CoV-2 testing

InterSystems, a global leader in healthcare information systems and technology solutions, has signed an agreement with Pure Health, the largest laboratory operator in the Gulf countries, to deploy InterSystems’ TrakCare Lab Enterprise (TCLE) system, the first and only laboratory business management solution, to support the UAE’s testing initiatives for SARS-CoV-2.

Patterns of common coronavirus infections could aid understanding of COVID-19

Coronavirus infections are a common cause of mild colds, infecting thousands of people every year in the UK. They mostly circulate in the winter in temperate regions where they are often referred to as ‘seasonal coronaviruses’. However, in contrast to many other infectious diseases, little is known about how often, and in whom, these viruses cause illnesses requiring medical attention. Data describing their patterns of infection are lacking because they are not tested for often.

Upcoming Events

Transfusing Wisely: a free-to-access SHOT webinar

Online
6 December 2022

Microbiology Society Annual Conference 2023

Birmingham International Convention Centre.
17-20 April 2023

British Society for Microbial Technology Annual Microbiology Conference

Royal Air Force Museum, Hendon, London
10 May 2023

Microscience Microscopy Congress 2023 (mmc 2023, incorporating EMAG 2023)

Manchester Central Conference Centre
4-6 July 2023

IBMS Congress 2023

ICC Birmingham
25-28 September 2023

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

Transfusing Wisely: a free-to-access SHOT webinar

Online
6 December 2022

Microbiology Society Annual Conference 2023

Birmingham International Convention Centre.
17-20 April 2023

British Society for Microbial Technology Annual Microbiology Conference

Royal Air Force Museum, Hendon, London
10 May 2023

Microscience Microscopy Congress 2023 (mmc 2023, incorporating EMAG 2023)

Manchester Central Conference Centre
4-6 July 2023

IBMS Congress 2023

ICC Birmingham
25-28 September 2023

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999 Fax: 01892 616177
www.step-communications.com
© 2022 Step Communications Ltd. Registered in England. Registration Number 3893025